December 20, 2020
A combination approach to treating a prevalent glioma subtype — including metabolic reprogramming, radiation, chemotherapy and immunotherapy — led to a complete regression of tumors in 60% of study mice, new research by the University of Michigan Rogel Cancer Center found. The findings, which appear in the Journal of Clinical Investigation, support the testing […]